Reno De Medici S.p.A. (BIT:RM) signed an irrevocable commitment to acquire Eska B.V. from Andlinger & Company, Inc. for approximately €160 million on June 8, 2021. Reno De Medici S.p.A. signed the binding contract to acquire Eska B.V. from Andlinger & Company, Inc. on July 8, 2021. At closing Reno De Medici S.p.A. will pay €146.8 million plus interests calculated applying a 3% interest rate for the period between December 31, 2020 and the closing date. A portion of €6.7 million of the purchase price will be held in escrow for two years after the closing date, as a security for any seller indemnification obligations resulting from the sale and purchase agreement. As provided for in the agreement, the purchase price will not be subject to any further adjustments. Reno De Medici will obtain the cash needed to close the acquisition by drawing on a specific external line of credit that is currently being negotiated. In the financial year ended December 31, 2020, Eska had gross sales of €149.7 million, EBITDA of €24.6 million and net profit of €12.7 million. The transaction is subject to completion of Dutch employee representative consultation procedures and fulfilment of certain conditions precedent, of which transaction financing. The transaction closing is expected to occur no later than July 31, 2021. The transaction closing is expected to occur no later than July 20, 2021. Intesa Sanpaolo (IMI Corporate & Investment Banking Division) acted as sole financial advisor while Banning acted as legal advisor and EY provided advice on accounting, fiscal, environmental and HR matters to Reno De Medici S.p.A. Lincoln International and Greenberg Traurig acted respectively as financial and legal advisor to Andlinger. Ernst & Young Participaties B.V. acted as Financial and Tax due diligence provider to Reno De Medici S.p.A. (BIT:RM) in the transaction. Reno De Medici S.p.A. (BIT:RM) completed the acquisition of Eska B.V. from Andlinger & Company, Inc. on July 13, 2021.